跳至主要内容
临床试验/NL-OMON35030
NL-OMON35030已完成2 期

Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients. A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-C

eids Universitair Medisch Centrum0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Advanced or metastatic colorectal cancer failing prior 5FU, oxaliplatin and irinotecan
  • - Mutation in codon 12, 13 or 61 of k-ras gene on tumor sample
  • - Adequate condition (WHO 0-2)
  • - Adequate organ function
  • - Written informed consent
  • - Age >= 18 years
  • - Progressive disease in the past 3 months

排除标准

  • - Prior EGFr inhibiting therapy
  • - Symptomatic brain metastasis
  • - Using verapamil or amiodarone
  • - Symptomatic hypothyroidism
  • - History of interstitial lung disease
  • - History of toxicity during statin use

研究者

相似试验